Tecna has signed a commercial agreement with BDS -BioDetection Systems b.v.- a company in the Netherlands that holds the rights to the technology DR CALUX®. This is a well known screening method for dioxins and dioxin-like PCBs. Tecna will be representing BDS in Italy and in Southern Europe, in particular Croatia, Serbia, Greece and Spain and will be spreading the DR CALUX® method, assisting laboratories that will decide to use this method.
The system consists of a bioassay based on engineered mammalian cells, so it is a method fully compliant with the requirements of the European Community laws with respect to dioxins analysis (particularly EU Commission Regulation 1883/2006).
Developed about 15 years ago, DR CALUX® is routinely used by many labs in Northern Europe and in the rest of the world.
Dr CALUX® has a sensitivity that is comparable to the instrumental method, but costs less, can be done faster, and doesn't require a very high investment. All these features make it very economical when large amounts of analysis have to be done in order to map out a large area or to guarantee the safety of a consistent flow of food.
For more information you can vist the BDS website at :